𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II study of tofacitinib (CP-690,550) combined with methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate

✍ Scribed by Yoshiya Tanaka; Makoto Suzuki; Hiroyuki Nakamura; Shigeyuki Toyoizumi; Samuel H. Zwillich; Tofacitinib Study Investigators


Publisher
Wiley (John Wiley & Sons)
Year
2011
Tongue
English
Weight
301 KB
Volume
63
Category
Article
ISSN
2151-464X

No coin nor oath required. For personal study only.